tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

STTK Stock Latest News

Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
Press ReleasesShattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
22h ago
STTK
Shattuck Labs price target lowered to $16 from $28 at H.C. Wainwright
PremiumThe Fly
Shattuck Labs price target lowered to $16 from $28 at H.C. Wainwright
12d ago
STTK
Trade Desk initiated, Best Buy upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Trade Desk initiated, Best Buy upgraded: Wall Street’s top analyst calls
15d ago
OC
BBY
Shattuck Labs downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Shattuck Labs downgraded to Neutral from Buy at BTIG
17d ago
STTK
Shattuck Labs Reports Promising Cancer Trial Outcomes
PremiumCompany Announcements
Shattuck Labs Reports Promising Cancer Trial Outcomes
18d ago
8K
STTK
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
PremiumPress ReleasesShattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
18d ago
STTK
Shattuck Labs reports ‘positive’ interim data from Phase 1B trial of SL-172154
PremiumThe Fly
Shattuck Labs reports ‘positive’ interim data from Phase 1B trial of SL-172154
18d ago
STTK
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
PremiumPress Releases
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
22d ago
STTK
Shattuck Labs announces ODD granted by FDA for SL-172154
PremiumThe Fly
Shattuck Labs announces ODD granted by FDA for SL-172154
22d ago
STTK
Shattuck Labs treatment of acute myeloid leukemia granted orphan designation
PremiumThe Fly
Shattuck Labs treatment of acute myeloid leukemia granted orphan designation
25d ago
STTK
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
PremiumPress Releases
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients
26d ago
STTK
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
PremiumPress Releases
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
2M ago
STTK
Shattuck Labs reports Q1 EPS (37c), consensus (45c)
PremiumThe FlyShattuck Labs reports Q1 EPS (37c), consensus (45c)
2M ago
STTK
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
2M ago
STTK
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress Releases
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
3M ago
STTK
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
PremiumPress Releases
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
3M ago
STTK
Shattuck Labs Boosts Board with Biotech Heavyweights
PremiumCompany Announcements
Shattuck Labs Boosts Board with Biotech Heavyweights
4M ago
8K
STTK
Shattuck Labs appoints Siegall, Sasser to board of directors
PremiumThe Fly
Shattuck Labs appoints Siegall, Sasser to board of directors
4M ago
IMNM
STTK
Shattuck Labs reports Q4 EPS (41c), consensus (57c)
PremiumThe Fly
Shattuck Labs reports Q4 EPS (41c), consensus (57c)
4M ago
STTK
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
PremiumPress ReleasesShattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
4M ago
STTK
Shattuck Labs Announces Participation in Upcoming March Conferences
PremiumPress Releases
Shattuck Labs Announces Participation in Upcoming March Conferences
4M ago
STTK
Ono enters drug discovery pact, option agreement with Shattuck Labs
PremiumThe Fly
Ono enters drug discovery pact, option agreement with Shattuck Labs
5M ago
STTK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >